CSTONE Announces CS2009 Clinical Validation Milestone at ESMO 2026
CSTONE says data from more than 300 patients support CS2009's mechanism, safety and broad antitumor activity.
CSTONE says data from more than 300 patients support CS2009's mechanism, safety and broad antitumor activity.